Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
NCT00003874 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003874 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia |
| Official title | A Phase I/II Study of Combined Enrichment of CD34+ Cells and Depletion of B-Cells From Peripheral Blood Stem Cell Components for Patients With B-Lymphoid Malignancies |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Biological, Procedure |
| Interventions | monoclonal antibody CD19, monoclonal antibody CD20, in vitro-treated peripheral blood stem cell transplantation |
| Start date | Feb 1, 1999 |
| Completion | Sep 1, 2001 |
| First posted | Jul 16, 2004 |
| Last update posted | Nov 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: